These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 9339195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer.
    Miller AA, Tolley EA, Niell HB.
    Clin Cancer Res; 1998 Jul; 4(7):1705-10. PubMed ID: 9676845
    [Abstract] [Full Text] [Related]

  • 7. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M, Chamouard V, Bressolle F, Boulieu R.
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [Abstract] [Full Text] [Related]

  • 8. Level of evidence for therapeutic drug monitoring for etoposide after oral administration.
    Gerritsen-van Schieveen P, Royer B, Therapeutic Drug Monitoring Group of the French Society of Pharmacology and Therapeutics.
    Fundam Clin Pharmacol; 2011 Jun; 25(3):277-82. PubMed ID: 20608987
    [Abstract] [Full Text] [Related]

  • 9. Low dose--high dose: what is the right dose? Pharmacokinetic modeling of etoposide.
    Würthwein G, Boos J.
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):303-8. PubMed ID: 11914910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD, Mathôt RA, Tibben MM, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Pharmacol Ther; 2000 Jun; 67(6):621-30. PubMed ID: 10872644
    [Abstract] [Full Text] [Related]

  • 14. Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
    Gauvin A, Pinguet F, Culine S, Astre C, Gomeni R, Bressolle F.
    Clin Cancer Res; 2000 Jul; 6(7):2690-5. PubMed ID: 10914711
    [Abstract] [Full Text] [Related]

  • 15. Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation.
    van der Meer AF, Marcus MA, Touw DJ, Proost JH, Neef C.
    Ther Drug Monit; 2011 Apr; 33(2):133-46. PubMed ID: 21383653
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion.
    Wada I, Yokouchi M, Saitoh H, Takada M, Nakabayashi T, Mino K, Honma T, Takeda T, Hirano K.
    Int J Clin Pharmacol Ther; 1999 May; 37(5):254-9. PubMed ID: 10363625
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignancies.
    Gregianin LJ, Brunetto AL, Di Leone L, Costa TD, Santos PP, Schwartsmann G.
    Med Sci Monit; 2002 Sep; 8(9):PI70-7. PubMed ID: 12218955
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.